Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis.
MRI
PNET
magnetic resonance imaging
pineal gland
pineoblastoma
retinoblastoma
trilateral retinoblastoma
Journal
Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
revised:
02
02
2021
received:
26
08
2020
accepted:
02
03
2021
pubmed:
4
5
2021
medline:
29
1
2022
entrez:
3
5
2021
Statut:
ppublish
Résumé
To determine the risk of patients with an early diagnosis of heritable retinoblastoma being diagnosed with TRb (or pineoblastoma) asynchronously in a later stage and its effect on screening. We updated the search (PubMed and Embase) for published literature as performed by our research group in 2014 and 2019. Trilateral retinoblastoma (TRb) patients were eligible for inclusion if identifiable as unique and the age at which TRb was diagnosed was available. The search yielded 97 new studies. Three new studies and eight new patients were included. Combined with 189 patients from the previous meta-analysis, the database included 197 patients. The main outcome was the percentage of asynchronous TRb in patients diagnosed before and after preset age thresholds of 6 and 12 months of age at retinoblastoma diagnosis. Seventy-nine per cent of patients with pineoblastoma are diagnosed with retinoblastoma before the age of 12 months. However, baseline MRI screening at time of retinoblastoma diagnosis fails to detect the later diagnosed pineal TRb in 89% of patients. We modelled that an additional MRI performed at the age of 29 months picks up 53% of pineoblastomas in an asymptomatic phase. The detection rate increased to 72%, 87% and 92%, respectively, with 2, 3 and 4 additional MRIs. An MRI of the brain in heritable retinoblastoma before the age of 12 months misses most pineoblastomas, while retinoblastomas are diagnosed most often before the age of 12 months. Optimally timed additional MRI scans of the brain can increase the asymptomatic detection rate of pineoblastoma.
Identifiants
pubmed: 33939299
doi: 10.1111/aos.14855
pmc: PMC9292554
doi:
Types de publication
Journal Article
Meta-Analysis
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e47-e52Informations de copyright
© 2021 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.
Références
Can J Ophthalmol. 2009;44 Suppl 2:S1-88
pubmed: 20237571
Br J Ophthalmol. 2009 Jan;93(1):21-3
pubmed: 18621794
Arch Pathol Lab Med. 2009 Aug;133(8):1199-202
pubmed: 19653709
Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr;6(2):197-207
pubmed: 28399338
Neuroradiology. 2016 Jul;58(7):713-21
pubmed: 27130617
Ophthalmology. 2020 May;127(5):601-607
pubmed: 32061409
Ophthalmology. 2016 Dec;123(12):2610-2617
pubmed: 27712844
Pediatr Blood Cancer. 2020 Jun;67(6):e28252
pubmed: 32187454
J Pediatr Hematol Oncol. 2007 Jan;29(1):53-6
pubmed: 17230067
Ophthalmology. 2017 Jun;124(6):859-872
pubmed: 28318638
Lancet Oncol. 2014 Sep;15(10):1157-67
pubmed: 25126964
Ophthalmol Retina. 2020 Mar;4(3):327-335
pubmed: 31948910
Neuroradiology. 2016 Jul;58(7):705-12
pubmed: 27130616
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
J Pediatr Hematol Oncol. 2020 Apr;42(3):238-243
pubmed: 31259824
Br J Ophthalmol. 2009 Jan;93(1):33-7
pubmed: 18838413
Ophthalmic Genet. 2016;37(1):116-8
pubmed: 24940935
Am J Ophthalmol. 2015 Dec;160(6):1116-1126.e5
pubmed: 26374932
BMJ Evid Based Med. 2018 Apr;23(2):60-63
pubmed: 29420178
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670